Last reviewed · How we verify
ISOFLAVONE
At a glance
| Generic name | ISOFLAVONE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Soy Tomato Juice to Improve Outcomes in Pancreatitis (PHASE1, PHASE2)
- Effectiveness of Genistein in Mild Cognitive Impairment (NA)
- Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study (PHASE2)
- Acute Equol Supplementation and Vascular Function in Women With and Without CKD (PHASE2)
- Effect of Equol Supplementation on Arterial Stiffness and Cognition in Healthy Volunteers (PHASE2)
- Equol and Vascular Function in Women With Chronic Kidney Disease (PHASE2)
- Polyphenol Metabolism and Personalized Nutrition in Menopause (PolyPause). (NA)
- Soy Isoflavonates Versus Placebo on Quality of Life in Menopausal Women (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ISOFLAVONE CI brief — competitive landscape report
- ISOFLAVONE updates RSS · CI watch RSS